Prostanoid F receptors elicit an inotropic effect in rat left ventricle by enhancing myosin light chain phosphorylation

Cardiovascular Research

Volumn 80, Issue 3, 2008, Pages 407-415

  Riise, Jon ^a   Nguyen, Cam H T ^a   Qvigstad, Eirik ^a   Sandnes, Dagny L ^a   Osnes, Jan Bjørn ^a   Skomedal, Tor ^a   Levy, Finn Olav ^a   Krobert, Kurt A ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Calcium sensitization; Contractile function; Inotropic agents; Signal transduction; Ventricular function

Indexed keywords

INOSITOL TRISPHOSPHATE; MYOSIN LIGHT CHAIN 2; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN PHOSPHATASE; PROSTANOID RECEPTOR; PROTEIN KINASE C;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CALMODULIN; CARDIAC MYOSINS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HEART VENTRICLES; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MYOCARDIAL CONTRACTION; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, PROSTAGLANDIN; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 56549094830     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn216     Document Type: Article

References (47)

1. Miller SB. Prostaglandins in health and disease: an overview. Semin Arthritis Rheum 2006;36:37-49.
2. Das UN. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 2000;215:145-152.
3. 2α induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo. Am J Physiol 1996;271:H2197-H2208.
4. 2α on intracellular pH, intracellular calcium, cell shortening and L-type calcium currents in rat myocytes. Cardiovasc Res 1998;40:538-545.
5. 2 in acetylcholine-induced positive inotropy in isolated mouse left atria. Pharmacology 2003;67:157-162.
6. 2 on isolated guinea pig atria. Mechanism of action. Pharmacol Res Commun 1983;15:735-749.
7. Montalescot G, Drobinski G, Meurin P, Maclouf J, Sotirov I, Philippe F et al. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol 1998;82:749-755.
8. 2α. J Pharmacol Exp Ther 1988;244:844-851.
9. Pönicke K, Giessler C, Grapow M, Heinroth-Hoffmann I, Becker K, Osten B et al. FP-receptor mediated trophic effects of prostanoids in rat ventricular cardiomyocytes. Br J Pharmacol 2000;129:1723-1731.
10. 1-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation. Am J Physiol Heart Circ Physiol 2002;283:H1471-H1480.
11. 1-adrenergic positive inotropic effect in human atrium. Cardiovasc Res 2005;65:211-220.
12. 4 receptors induced in the acute failing heart. Circ Res 2005;97:268-276.
13. Rossmanith GH, Hoh JF, Turnbull L, Ludowyke RI. Mechanism of action of endothelin in rat cardiac muscle: cross-bridge kinetics and myosin light chain phosphorylation. J Physiol 1997;505(Pt 1):217-227.
14. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle [published erratum appears in Nature 1994;372:812]. Nature 1994;372:231-236.
15. Rajashree R, Blunt BC, Hofmann PA. Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heart. Am J Physiol Heart Circ Physiol 2005;289:H1736-H1743.
16. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K et al. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 2003;92:411- 418.
17. 2α. Am J Physiol 1991;261:C253-C258.
18. 1 adrenoceptor-mediated and β adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle. J Pharmacol Exp Ther 1997;280:721-729.
19. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
20. Hathaway DR, Haeberle JR. A radioimmunoblotting method for measuring myosin light chain phosphorylation levels in smooth muscle. Am J Physiol 1985;249:C345-C351.
21. 2α (FP) receptor. J Pharmacol Exp Ther 1999;290:1278-1284.
22. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001;41:661- 690.
23. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996;273:245-248.
24. q in cDNA-transfected Chinese hamster ovary cells. Biochem Biophys Res Commun 1994;200:756-762.
25. Reig JA, Viniegra S, Ballesta JJ, Palmero M, Guitierrez LM. Naphthalene-sulfonamide derivatives ML9 and W7 inhibit catecholamine secretion in intact and permeabilized chromaffin cells. Neurochem Res 1993;18:317-323.
26. Asano M. Divergent pharmacological effects of three calmodulin antagonists, N-(6-aminohexyl)-5-chloro-1-naphtalenesulfonamide (W-7), chlorpromazine and calmidazolium, on isometric tension development and myosin light chain phosphorylation in intact bovine tracheal smooth muscle. J Pharmacol Exp Ther 1989;251:764-773.
27. Chan JY, Takeda M, Briggs LE, Graham ML, Lu JT, Horikoshi N et al. Identification of cardiac-specific myosin light chain kinase. Circ Res 2008;102:571-580.
28. Bain J, McLauchlan H, Elliott M, Cohen P. The specificities of protein kinase inhibitors: an update. Biochem J 2003;371:199-204.
29. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997;389:990-994.
30. Okamoto R, Kato T, Mizoguchi A, Takahashi N, Nakakuki T, Mizutani H et al. Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart. Cell Signal 2006;18:1408-1416.
31. Ito M, Nakano T, Erdodi F, Hartshorne DJ. Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 2004;259:197-209.
32. Solaro RJ. Myosin light chain phosphatase: a Cinderella of cellular signaling. Circ Res 2000;87:173-175.
33. Newton AC. Diacylglycerol's affair with protein kinase C turns 25. Trends Pharmacol Sci 2004;25:175-177.
34. Gekeler V, Boer R, Uberall F, Ise W, Schubert C, Utz I et al. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance. Br J Cancer 1996;74:897-905.
35. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771-15781.
36. ε signaling. Br J Pharmacol 2006;148:991-1000.
37. 1- adrenoceptor-induced negative inotropic response in rat ventricles. J Biomed Sci 2000;7:380-389.
38. α regulates cardiac contractility and propensity toward heart failure. Nat Med 2004;10:248-254.
39. α improves contractile function in reconstituted heart tissue. J Mol Cell Cardiol 2007;43:371-376.
40. α/β enhances cardiac contractility and attenuates heart failure. Circulation 2006;114:574-582.
41. Bare DJ, Kettlun CS, Liang M, Bers DM, Mignery GA. Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. J Biol Chem 2005;280:15912-15920.
42. Mackenzie L, Roderick HL, Proven A, Conway SJ, Bootman MD. Inositol 1,4,5-trisphosphate receptors in the heart. Biol Res 2004;37:553- 557.
43. 3)-receptor type 2-deficient mice. Circ Res 2005;96:1274-1281.
44. 2+ store throughout cardiac myocyte. Circ Res 2006;99:283-291.
45. 2+ release. FASEB J 2002;16:1145-1150.
46. 13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med 2008;14:64-68.
47. 13 in agonist-induced vascular smooth muscle contraction. Circ Res 2000;87:221-227.